RESUMEN
RESUMEN La diabetes mellitus tipo 2 se asocia a un incremento del riesgo de mortalidad por enfermedad cardiovascular y es una afección frecuente dentro de los pacientes con enfermedad cardiovascular establecida. El tratamiento adecuado permite mejorar la calidad de vida del paciente y disminuir la morbilidad y la mortalidad por esta y otras causas. La rehabilitación cardiovascular ha demostrado ser una terapéutica eficaz y beneficiosa en los pacientes con diabetes mellitus tipo 2. Por eso, se revisaron 70 referencias bibliográficas con el objetivo de describir elementos importantes sobre su tratamiento, que incluye estrategias farmacológicas, no farmacológicas y la rehabilitación cardiovascular.
ABSTACT Type 2 diabetes mellitus is associated with an increased risk of mortality from cardiovascular disease and it is a common condition within patients with established cardiovascular disease. Appropriate treatment can improve the patient's quality of life and decrease morbidity and mortality from this and other causes. Cardiovascular rehabilitation has been shown to be an effective and beneficial therapy in patients with type 2 diabetes mellitus. For this reason, 70 bibliographic references were reviewed with the aim of describing important elements of its treatment, which includes pharmacological and non-pharmacological strategies and cardiovascular rehabilitation.
RESUMEN
Objective:To evaluate the standardized usage of oral antidiabetic agents in inpatients to provide reference for the pre -scription standardization .Methods:A retrospective study was used to evaluate the prescriptions of oral antidiabetic agents in inpatients during January and March in 2017 , and statistical analysis was conducted on drug usage and standardization evaluation .Results:There were 886 medication plans including 4,397 prescriptions, which involved in 13 kinds of antidiabetic agents .Metformin and acarbose a-gents were used most frequently .The non-standardization rate was 70.54％with 66.03％unlabeled accurate time for oral administra-tion and 4.51％ labeled wrong time for oral administration .Twelve antidiabetic agents existed non-standardized applications ( >50％) .Conclusion:The main problem in the non-standardized usage of antidiabetic agents is leaving the special time for oral adminis -tration of antidiabetic agents out of account , which not only affect the best efficacy , but also reduce patients ' compliance .It' s neces-sary to standardize the prescriptions of antidiabetic agents to improve the standardization of medication therapy .
RESUMEN
OBJECTIVE:To probe into the status quo and tendency of the utilization of oral hypoglycemic agents in university-affiliated hospitals in Beijing area.METHODS:As one of the zero-difference rate drugs that won the bid,the oral hypoglycemic drugs purchased between 2007 and 2008 by 18 university hospitals in Beijing area were analyzed statistically in respect of the drug variety,DDDs and DDC etc.RESULTS:Of all the oral hypoglycemic agents purchased,?-glycosidase inhibitors took the lead in terms of purchase sum,DDDs as well as DDC.Gliquidone Tablets ranked at the second place and metformin enteric-coated tablets(0.25 g)the third place in terms of DDDs while the DDC of the two drugs ranked at the fifth and the sixth,respectively.CONCLUSION:?-glycosidase inhibitors are the first choice drugs for patients with diabetes in university hospitals in Beijing area.However,the purchase sum and medication person-time of it showed poor synchronism.The utilization of Gliquidone Tablets and Metformin Enteric-coated Tablets(0.25 g)were rational and economicalwhich thus deserve to be used preferably in clinical practice.